These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 2054272)

  • 1. Evaluation of potential pharmacodynamic and pharmacokinetic interactions between verapamil and propranolol in normal subjects.
    Murdoch DL; Thomson GD; Thompson GG; Murray GD; Brodie MJ; McInnes GT
    Br J Clin Pharmacol; 1991 Mar; 31(3):323-32. PubMed ID: 2054272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic adverse hemodynamic interaction between oral verapamil and propranolol.
    Carruthers SG; Freeman DJ; Bailey DG
    Clin Pharmacol Ther; 1989 Oct; 46(4):469-77. PubMed ID: 2791449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmacokinetic and pharmacodynamic interactions of ramipril with propranolol.
    van Griensven JM; Seibert-Grafe M; Schoemaker HC; Frölich M; Cohen AF
    Eur J Clin Pharmacol; 1993; 45(3):255-60. PubMed ID: 8276050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction between oral verapamil and beta-blockers during submaximal exercise: relevance of ancillary properties.
    Bailey DG; Carruthers SG
    Clin Pharmacol Ther; 1991 Apr; 49(4):370-6. PubMed ID: 2015727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of metoprolol and verapamil administered separately and concurrently after single doses on liver blood flow and drug disposition.
    Bauer LA; Horn JR; Maxon MS; Easterling TR; Shen DD; Strandness DE
    J Clin Pharmacol; 2000 May; 40(5):533-43. PubMed ID: 10806607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of captopril, propranolol, and verapamil on arterial pulse wave velocity and other cardiovascular parameters in healthy volunteers.
    Kähönen M; Ylitalo R; Kööbi T; Turjanmaa V; Ylitalo P
    Int J Clin Pharmacol Ther; 1998 Sep; 36(9):483-9. PubMed ID: 9760009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and pharmacodynamics of verapamil in combination with atenolol, metoprolol and propranolol.
    Warrington SJ; Holt D; Johnston A; Fitzsimons TJ
    Br J Clin Pharmacol; 1984; 17 Suppl 1(Suppl 1):37S-44S. PubMed ID: 6146339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pharmacodynamic and pharmacokinetic interaction between single doses of flecainide acetate and verapamil: effects on cardiac function and drug clearance.
    Holtzman JL; Finley D; Mottonen L; Berry DA; Ekholm BP; Kvam DC; McQuinn RL; Miller AM
    Clin Pharmacol Ther; 1989 Jul; 46(1):26-32. PubMed ID: 2501057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Verapamil disposition and cardiovascular effects in elderly patients after single intravenous and oral doses.
    Carosella L; Menichelli P; Alimenti M; Zuccala G; Gemma A; Cocchi A; Carbonin PU
    Cardiovasc Drugs Ther; 1989 Jun; 3(3):417-25. PubMed ID: 2487538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of propranolol and of verapamil on heart rate and blood pressure in hyperthyroidism.
    Clozel JP; Danchin N; Genton P; Thomas JL; Cherrier F
    Clin Pharmacol Ther; 1984 Jul; 36(1):64-9. PubMed ID: 6734051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical pharmacokinetics of verapamil.
    Hamann SR; Blouin RA; McAllister RG
    Clin Pharmacokinet; 1984; 9(1):26-41. PubMed ID: 6362951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmacology of verapamil. IV. Kinetic and dynamic effects after single intravenous and oral doses.
    McAllister RG; Kirsten EB
    Clin Pharmacol Ther; 1982 Apr; 31(4):418-26. PubMed ID: 7060323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions between cilazapril and propranolol in man; plasma drug concentrations, hormone and enzyme responses, haemodynamics, agonist dose-effect curves and baroreceptor reflex.
    Belz GG; Essig J; Kleinbloesem CH; Hoogkamer JF; Wiegand UW; Wellstein A
    Br J Clin Pharmacol; 1988 Nov; 26(5):547-56. PubMed ID: 2974715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular and pharmacokinetic consequences of combined administration of verapamil and propranolol in dogs.
    Hamann SR; Kaltenborn KE; Vore M; Tan TG; McAllister RG
    Am J Cardiol; 1985 Jul; 56(1):147-56. PubMed ID: 4014021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic and pharmacodynamic interactions during multiple-dose administration of nisoldipine and propranolol.
    Shaw-Stiffel TA; Walker SE; Ogilvie RI; Leenen FH
    Clin Pharmacol Ther; 1994 Jun; 55(6):661-9. PubMed ID: 8004882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of verapamil and beta blockers in systemic hypertension.
    Dargie H; Cleland J; Findlay I; Murray G; McInnes G
    Am J Cardiol; 1986 Feb; 57(7):80D-82D. PubMed ID: 3513518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular depression by verapamil: reversal by glucagon and interactions with propranolol.
    Jolly SR; Kipnis JN; Lucchesi BR
    Pharmacology; 1987; 35(5):249-55. PubMed ID: 3423100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic and pharmacodynamic interactions between nisoldipine and propranolol.
    Levine MA; Ogilvie RI; Leenen FH
    Clin Pharmacol Ther; 1988 Jan; 43(1):39-48. PubMed ID: 2826066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alteration of propranolol pharmacokinetics and pharmacodynamics by quinidine in man.
    Yasuhara M; Yatsuzuka A; Yamada K; Okumura K; Hori R; Sakurai T; Kawai C
    J Pharmacobiodyn; 1990 Nov; 13(11):681-7. PubMed ID: 2093126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative pharmacodynamics and pharmacokinetics of conventional and long-acting propranolol.
    Garg DC; Jallad NS; Mishriki A; Chalavarya G; Kraml M; Fencik M; Weidler DJ
    J Clin Pharmacol; 1987; 27(5):390-6. PubMed ID: 3693583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.